Mission statement: The Cancer Research Institute (CRI), established in 1953, is the world’s only non-profit organization dedicated exclusively to transforming cancer patient care by advancing scientific efforts that are leading to new and effective immune system-based strategies to treat, control, and prevent cancer.  Guided by a world-renowned Scientific Advisory Council that includes four Nobel laureates and twenty-nine members of the National Academy of Sciences, CRI has invested $260 million in support of research conducted by immunologists and tumor immunologists at the world’s leading medical centers and universities, and has contributed to many of the key scientific advances that have led to the recent explosion of interest in the potential for immunotherapy to change the face of cancer treatment.  To accelerate the pace of progress in the field, CRI convenes and coordinates global collaborations among academics, industry scientists and decision makers, regulatory representatives, and health research associations focused on discovery, development, and refinement of new cancer immunotherapies.  A founding visionary and scientific leader in tumor immunology, CRI is ushering in a new era of medical progress to bring more treatment options to cancer patients sooner.  For more information, visit http://www.cancerresearch.org.